加衛苗 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "加衛苗" in Chinese language version.

refsWebsite

Global rank Chinese rank

9web.archive.org

1^st place

5nih.gov

4^th place

5^th place

3doi.org

2^nd place

23^rd place

3fda.gov

447^th place

581^st place

2cdc.gov

218^th place

198^th place

2westminster.edu

low place

1europa.eu

68^th place

209^th place

1medscape.com

719^th place

889^th place

1reuters.com

49^th place

81^st place

1jci.org

low place

1bloomberg.com

99^th place

225^th place

1merck.com

6,464^th place

3,752^nd place

1webcitation.org

24^th place

29^th place

bloomberg.com

Cortez, Michelle Fay; Pettypiece, Shannon. Merck Cancer Shot Cuts Genital Warts, Lesions in Men (Update2). Bloomberg News. 2008-11-13 [2009-11-12]. ^{[永久失效連結]}

cdc.gov

Markowitz, L. E.; Dunne, E. F.; Saraiya, M.; Lawson, H. W.; Chesson, H.; Unger, E. R.; Centers for Disease Control Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (PDF). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2007, 56 (RR-2): 1–24 [2016-03-06]. PMID 17380109. （原始内容存档 (PDF)于2015-09-24）.
Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP) (PDF). MMWR. Morbidity and mortality weekly report. 2010, 59 (20): 630–632 [2016-03-06]. PMID 20508594. （原始内容存档 (PDF)于2015-09-24）.

doi.org

Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J. Clin. Invest. May 2006, 116 (5): 1167–73 [2009-11-12]. PMC 1451224 . PMID 16670757. doi:10.1172/JCI28607. （原始内容存档于2008-12-29）.
Muñoz N, Bosch FX, Castellsagué X. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer. August 2004, 111 (2): 278–85. PMID 15197783. doi:10.1002/ijc.20244.
Haupt, Richard; Sings, Heather. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil. Journal of Adolescent Health. November 2011, 49 (5): 467–475. PMID 22018560. doi:10.1016/jodohealth.2011.07.003.

europa.eu

emea.europa.eu

Silgard European Public Assessment Report. 歐洲藥品管理局. 2009-09-25 [2009-12-05]. （原始内容存档于2009-12-26）.

fda.gov

FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers (新闻稿). 美國食品藥品監督管理局 (FDA). 2008-09-12 [2009-11-11]. （原始内容存档于2010-03-06）.
Gardasil Vaccine Safety. Vaccine Safety & Availability. 美國食品藥品監督管理局 (FDA). 2009-08-20 [2009-11-11]. （原始内容存档于2009-11-15）.
FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV (press release). 2014-12-10 [2015-02-28]. （原始内容存档于2015-01-10）.

jci.org

Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J. Clin. Invest. May 2006, 116 (5): 1167–73 [2009-11-12]. PMC 1451224 . PMID 16670757. doi:10.1172/JCI28607. （原始内容存档于2008-12-29）.

medscape.com

Waknine, Yael. International Approvals: Singulair and Gardasil/Silgard. Medscape Today. 2006-10-02 [2008-12-18]. （原始内容存档于2013-05-20）.

merck.com

Gardasil full prescribing information (PDF). Merck & Co. [2009-11-11]. （原始内容存档 (PDF)于2012-03-18）.

nih.gov

ncbi.nlm.nih.gov

Markowitz, L. E.; Dunne, E. F.; Saraiya, M.; Lawson, H. W.; Chesson, H.; Unger, E. R.; Centers for Disease Control Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (PDF). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2007, 56 (RR-2): 1–24 [2016-03-06]. PMID 17380109. （原始内容存档 (PDF)于2015-09-24）.
Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP) (PDF). MMWR. Morbidity and mortality weekly report. 2010, 59 (20): 630–632 [2016-03-06]. PMID 20508594. （原始内容存档 (PDF)于2015-09-24）.
Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J. Clin. Invest. May 2006, 116 (5): 1167–73 [2009-11-12]. PMC 1451224 . PMID 16670757. doi:10.1172/JCI28607. （原始内容存档于2008-12-29）.
Muñoz N, Bosch FX, Castellsagué X. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer. August 2004, 111 (2): 278–85. PMID 15197783. doi:10.1002/ijc.20244.
Haupt, Richard; Sings, Heather. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil. Journal of Adolescent Health. November 2011, 49 (5): 467–475. PMID 22018560. doi:10.1016/jodohealth.2011.07.003.

reuters.com

Richwine, Lisa. UPDATE 2-U.S. health officials back safety of Merck vaccine. Reuters. 2009-08-20 [2009-11-12]. （原始内容存档于2009-08-27）.

web.archive.org

Silgard European Public Assessment Report. 歐洲藥品管理局. 2009-09-25 [2009-12-05]. （原始内容存档于2009-12-26）.
Waknine, Yael. International Approvals: Singulair and Gardasil/Silgard. Medscape Today. 2006-10-02 [2008-12-18]. （原始内容存档于2013-05-20）.
Richwine, Lisa. UPDATE 2-U.S. health officials back safety of Merck vaccine. Reuters. 2009-08-20 [2009-11-12]. （原始内容存档于2009-08-27）.
Markowitz, L. E.; Dunne, E. F.; Saraiya, M.; Lawson, H. W.; Chesson, H.; Unger, E. R.; Centers for Disease Control Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (PDF). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2007, 56 (RR-2): 1–24 [2016-03-06]. PMID 17380109. （原始内容存档 (PDF)于2015-09-24）.
Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP) (PDF). MMWR. Morbidity and mortality weekly report. 2010, 59 (20): 630–632 [2016-03-06]. PMID 20508594. （原始内容存档 (PDF)于2015-09-24）.
Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. J. Clin. Invest. May 2006, 116 (5): 1167–73 [2009-11-12]. PMC 1451224 . PMID 16670757. doi:10.1172/JCI28607. （原始内容存档于2008-12-29）.
FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers (新闻稿). 美國食品藥品監督管理局 (FDA). 2008-09-12 [2009-11-11]. （原始内容存档于2010-03-06）.
Gardasil Vaccine Safety. Vaccine Safety & Availability. 美國食品藥品監督管理局 (FDA). 2009-08-20 [2009-11-11]. （原始内容存档于2009-11-15）.
FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV (press release). 2014-12-10 [2015-02-28]. （原始内容存档于2015-01-10）.

webcitation.org

Gardasil full prescribing information (PDF). Merck & Co. [2009-11-11]. （原始内容存档 (PDF)于2012-03-18）.

westminster.edu

credoreference.com.wc-ezproxy.westminster.edu

The Ethics of Vaccination. Springer Publishing Company. [2013-09-29].
The Ethics of vaccination. Springer Publishing Company. [2013-10-03].